SOURCE: Masimo

Masimo

April 13, 2015 10:10 ET

Masimo Announces Patient SafetyNet Series 5000 With Iris Connectivity and MyView

Bringing Connected Care and Enhancing Clinician Workflow From the Operating Room to the Medical and Surgical Unit

IRVINE, CA--(Marketwired - Apr 13, 2015) - Masimo (NASDAQ: MASI) today announced the debut of Patient SafetyNet Series 5000™ along with Iris™ Connectivity and MyView™ through the Root® patient monitoring and connectivity platform at the HIMSS Annual Conference and Exhibition in Chicago. This series of Patient SafetyNet offers a new level of interoperability designed to enhance clinician workflows and reduce the cost of care from operating rooms to medical-surgical units.

Today's medical-surgical units utilize intermittent vital signs spot checks, standalone monitoring systems, and a host of disparate legacy devices, which become isolated stores of valuable patient data. Existing approaches for device interoperability typically require separate hardware, software, and/or network infrastructure, which can clutter the patient room, increase complexity, burden IT management, and increase costs.

A New Level of Data Integration & Workflow Optimization

Masimo's Patient SafetyNet Series 5000 with Iris enables Root to intake data from all devices connected to the patient, acting as an in-room patient monitor and connectivity hub. Alarms and alerts for all devices are seamlessly forwarded to the patient's clinician and all device data are effortlessly documented in the patient's electronic medical record (EMR).

The patient-centric user interface of Patient SafetyNet Series 5000 displays near real-time data from all devices, providing a single unified dashboard of patient information. Having such a holistic view can enable caregivers to more quickly assess patient status allowing for faster clinical decisions.

To simplify documentation of patient data, Root enables clinicians to easily verify and send patient vitals, as well as all connected medical device information data to the EMR directly from Root. Data can also be sent to the EMR periodically. An interface between the Patient SafetyNet Series 5000 Appliance and the hospital ADT system allows clinicians to receive ADT information on Root for positive patient identification at the bedside. Clinicians can also manually enter additional data on the Root device, including temperature, blood pressure, level of consciousness, pain score, and urine output.

Personalized Displays & Reporting with MyView™

MyView is a wireless, presence-detection system that enables clinicians to automatically display customized clinical profiles on Masimo devices, such as Root, Radical-7, and the Patient SafetyNet View Station. When a clinician approaches the device, a clinician-worn MyView badge signals the device to display a preselected set of parameters and waveforms tailored to the individual clinician's preferences.

MyView allows clinicians the ability to consume medical device information in a manner that is most conducive to optimizing their workflow, while the presence mapping data collected by all the Masimo devices can provide information on how clinicians spend time with their patients. This allows nursing leadership and management the opportunity to examine analytical data on patient and clinician interactions to optimize workflows across the unit, hospital, or hospital system.

In 2012, The Joint Commission Sentinel Event Alert on the safe use of opioids in hospitals recommended implementation of better dosing along with continuous oxygenation and ventilation monitoring (instead of spot checks) in post-surgical patients.1 After implementing Masimo SET® and Patient SafteyNet remote monitoring and wireless notification system in a post-surgical floor where only intermittent spot-checking was used before, Dartmouth-Hitchcock Medical Center reduced rapid response activations by 65%* and ICU transfers by 48%,2 and realized $1.48 million in annual opportunity cost savings. Based on the results in this single unit, Dartmouth expanded the system to all seven of its medical-surgical units and had zero patients experience brain injury or death over a five-year period.3

"Medical device interoperability is a key component to improving clinical decision making, patient safety, and clinician workflow," said Joe Kiani, founder and CEO of Masimo. "Unfortunately many technical and corporate barriers can make achieving interoperability challenging for hospitals. Our goal with Patient SafetyNet Series 5000, Root with Iris, and MyView is to eliminate these barriers and offer innovation that automates patient care with open, scalable, and standards-based connectivity solutions."

1 The Joint Commission Sentinel Event Alert, 2012;49
2 Taenzer, Andreas H.; Pyke, Joshua B.; McGrath, Susan P.; Blike, George T. "Impact of Pulse Oximetry Surveillance on Rescue Events and Intensive Care Unit Transfers: A Before-and-After Concurrence Study." Anesthesiology, February 2010, Vol. 112, Issue 2.
* The calculation of reduced rapid response activations by 65% was based on reduction of rescue events from 3.4 per 1000 discharges to 1.2 per 1000 discharges.
3 Taenzer A, Blike G, McGrath S, Pyke J, Herrick M, Renaud C, Morgan J. "Postoperative Monitoring - The Dartmouth Experience." Anesthesia Patient Safety Foundation Newsletter Spring-Summer 2012.

About Masimo

Masimo (NASDAQ: MASI) is the global leader in innovative noninvasive monitoring technologies that significantly improve patient care-helping solve "unsolvable" problems. In 1995, the company debuted Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo SET®, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 indepensdent and objective studies have shown that Masimo SET® outperforms other pulse oximetry technologies, even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced rainbow Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and Pleth Variability Index (PVI®), in addition to SpO2, pulse rate, and perfusion index (PI). Additional information about Masimo and its products may be found at www.masimo.com. @masimoinnovates

Forward-Looking Statements

This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: risks related to our assumptions that Masimo Patient SafetyNet can help keep patients safer by noninvasively, continuously measuring and tracking their underlying physiological condition to help hospitals avoid preventable patient deaths and injuries associated with failure to rescue events; risks related to our assumptions regarding the repeatability of clinical results; as well as other factors discussed in the "Risk Factors" section of our most recent reports filed with the Securities and Exchange Commission ("SEC"), which may be obtained for free at the SEC's website at www.sec.gov. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarify these statements or the "Risk Factors" contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.

Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care... by Taking Noninvasive Monitoring to New Sites and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI are trademarks or registered trademarks of Masimo.

Contact Information